Healthcare Triangle

HCTI

Market cap $15.4M

PLEASANTON, CA / ACCESS Newswire / October 14, 2025 / The market always appreciates a great company story. The problem is that it often rewards the ones that sound big, not necessarily the ones that are big.

PLEASANTON, CA / ACCESS Newswire / October 13, 2025 / Healthcare Triangle Inc. (NASDAQ:HCTI) published a recent press release that included a headline that could've been mistaken for corporate filler- "executes aggressive growth." But this one hits different.

Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc. (Nasdaq:HCTI), a leader in digital transformation solutions for the healthcare and life sciences industries, has announced two significant developments within the past few days that highlight the company's growing momentum in the AI-powered healthcare technology sector. In an impressive one-week period, Healthcare Triangle has both signed a Letter of Intent to acquire Spain-based Teyame.AI in a transaction expected to generate approximately $34 million in incremental annual revenue, and announced that its wholly-owned subsidiary QuantumNexis has processed over $20 million in revenue generated by healthcare providers who rely on the Ezovion platform; and the consumption revenue with projections to reach $37 million within six months.

PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Some companies tiptoe into innovation. Healthcare Triangle Inc. (NASDAQ: HCTI ) prefers to kick the door down.

PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has signed a non-binding Letter of Intent (LOI) to acquire the assets of Teyame.AI LLC ("Teyame"), a Spain-based leader in AI-powered omnichannel customer experience (CX) solutions.

JERSEY CITY, N.J. , Oct. 8, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced it has entered into warrant exercise agreements with certain existing accredited and institutional investors to exercise outstanding warrants to purchase an aggregate of 239,051 of the Company's shares of common stock (the "Existing Warrants").

JERSEY CITY, N.J. , Oct. 3, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced today it has entered into warrant exercise agreements with certain existing accredited and institutional investors to exercise outstanding warrants to purchase an aggregate of 377,702 of the Company's shares of common stock (the "Existing Warrants").

JERSEY CITY, N.J. , Oct. 2, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, has entered into warrant exercise agreements with three existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 812,775 of the Company's shares of common stock (the "Existing Warrants").

PLEASANTON, Calif. , Oct. 1, 2025 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced a significant milestone for its wholly-owned subsidiary, QuantumNexis.

New York, NY, March 07, 2025 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is pleased to announce a series of strategic transactions completed in February 2025, reinforcing its position as a trusted financial partner for companies across diverse industries.